Search

12 May 2025 - Learn more about providing naloxone as part of the Take Home Naloxone program initiative, and how to register as or apply to be a provider.

15 November 2019 - Learn about the symptoms of an opioid overdose or adverse reaction. Find out who is at risk of overdosing or experiencing an adverse reaction and what to do in an emergency.

16 June 2025 - This public summary document outlines Stoma Product Assessment Panel recommendations, after assessing products for the Stoma Appliance Scheme Schedule in October 2023.

3 June 2025 - This fact sheet is for current prescribers (treating physicians) with patients requiring treatment for Fabry disease. It explains how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS.

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for late-infantile onset Batten disease under the Life Saving Drugs Program.

30 June 2025 - Advice for health providers and other users of the Medicare Benefits Schedule on the interpretation and application of MBS items, explanatory notes and associated legislation, to assist them in billing Medicare correctly.

11 June 2025 - This user guide for hospitals and private health insurers explains how to submit Hospital Casemix Protocol (HCP) and Private Hospital Data Bureau (PHDB) data.

1 August 2024 - This public summary document outlines Stoma Product Assessment Panel recommendations, after assessing products for the Stoma Appliance Scheme Schedule in May 2024.

2 May 2022 - Healthy ears and healthy hearing help people connect with language and culture, help kids learn at school, and increase job opportunities. Our policies and programs aim to prevent, treat and monitor ear disease in Aboriginal and Torres Strait Islander people.

29 July 2025 - This document provides a list of biosimilar medicines that are subsidised under the Pharmaceutical Benefits Scheme (PBS).